Susquehanna Fundamental Investments’s Amedisys AMED Stock Holding History

Susquehanna Fundamental Investments’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-33,483	Closed	-$3.13M	–	88
2023 Q3	$3.13M	Hold	33,483	–	–	0.2%	115
2023 Q2	$3.06M	Sell	33,483 -2,803	-8%	-$230K	0.11%	202
2023 Q1	$2.67M	Sell	36,286 -1,966	-5%	-$170K	0.06%	316
2022 Q4	$3.2M	Buy	38,252 +5,099	+15%	+$460K	0.06%	372
2022 Q3	$3.21M	Buy	+33,153	New	+$3.95M	0.05%	452
2022 Q1	$6.48M	Sell	37,635 -8,915	-19%	-$1.33M	0.13%	231
2021 Q4	$7.54M	Buy	46,550 +20,855	+81%	+$3.35M	0.2%	125
2021 Q3	$3.83M	Sell	25,695 -28,105	-52%	-$5.84M	0.07%	375
2021 Q2	$13.2M	Sell	53,800 -20,178	-27%	-$5.29M	0.24%	91
2021 Q1	$19.6M	Hold	73,978	–	–	0.34%	49
2020 Q4	$21.7M	Hold	73,978	–	–	0.4%	19
2020 Q3	$17.5M	Hold	73,978	–	–	0.52%	9
2020 Q2	$14.7M	Buy	+73,978	New	+$13.8M	0.7%	12

Other funds holding AMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Susquehanna Fundamental Investments's AMED Position: Q4 2023 in Review

Susquehanna Fundamental Investments sold out of Amedisys (AMED) in Q4 2023, closing a stake of 33,483 shares — an estimated $3.13M sold.

Susquehanna Fundamental Investments first reported a position in AMED in Q2 2020 and held it in 13 quarters. The position peaked at $21.7M in Q4 2020. 288 funds tracked by Wall St. Rank hold AMED as of Q4 2023.

Susquehanna Fundamental Investments reported no remaining Amedisys position as of Q4 2023 after selling out during the quarter.
Susquehanna Fundamental Investments sold 33,483 Amedisys shares in Q4 2023, an estimated $3.13M.
Susquehanna Fundamental Investments first reported a position in Amedisys in Q2 2020 and held it in 13 quarters.
Susquehanna Fundamental Investments's Amedisys position peaked at $21.7M in Q4 2020.
288 funds tracked by Wall St. Rank held Amedisys as of Q4 2023.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2023, filed 14 Feb 2024.